Medicare Enrolled
Dr. Francis Mogollon Duffo, M.D.
Hematology · Kissimmee, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mogollon Duffo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mogollon Duffo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mogollon Duffo
Dr. Francis Mogollon Duffo is a hematology specialist in Kissimmee, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Mogollon Duffo performed 66,513 Medicare services across 1,849 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mogollon Duffo received a total of $1,826 from 23 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mogollon Duffo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ 66,513 Medicare services
$1,826 industry payments
Medicare Practice Summary
Medicare Utilization ↗66,513
Medicare services
Bottom 43% in FL for hematology
1,849
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,047 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
11,250 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 10,800 | $42 | $104 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
9,750 | $1 | $3 |
| Paclitaxel chemotherapy injection | 8,676 | $0 | $2 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
7,100 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
4,960 | $6 | $21 |
| Denosumab injection (Prolia/Xgeva) | 3,540 | $18 | $44 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
2,525 | $33 | $98 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,816 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 850 | $1 | $27 |
| Injection, granisetron hydrochloride, 100 mcg | 501 | $0 | $4 |
| Injection, fulvestrant, 25 mg | 480 | $8 | $160 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
350 | $21 | $57 |
| Injection, leucovorin calcium, per 50 mg | 349 | $3 | $8 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
345 | $92 | $259 |
| Anti-nausea injection (ondansetron/Zofran) | 332 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
311 | $85 | $255 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
307 | $10 | $42 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
253 | $2 | $6 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
236 | $2 | $32 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
211 | $12 | $36 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
159 | $45 | $133 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
146 | $86 | $229 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
129 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
128 | $20 | $56 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
92 | $18 | $52 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
92 | $130 | $370 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
85 | $48 | $127 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 73 | $134 | $1,030 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
65 | $57 | $156 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
63 | $4 | $12 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
62 | $21 | $66 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
55 | $54 | $142 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
50 | $2 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $127 | $359 |
| Leukocyte-reduced red blood cell unit A unit of red blood cells that has been processed to remove white blood cells (leukocytes) before transfusion. |
40 | $46 | $564 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
39 | $15 | $41 |
| Blood or blood product transfusion The administration of whole blood or specific blood components into a patient's bloodstream. |
35 | $27 | $76 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
35 | $10 | $25 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
34 | $25 | $96 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
29 | $42 | $109 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $99 | $196 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
23 | $130 | $317 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
21 | $15 | $39 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
21 | $16 | $50 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
15 | $61 | $190 |
| New patient office visit, complex (60-74 min) | 14 | $142 | $444 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.1% high complexity
78.4% medium
1.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,826
Total received (2018-2024)
Avg $261/year across 7 years
Bottom 21% in FL for hematology
23
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,511 (82.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$315 (17.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22
2023
$102
2022
$72
2021
$162
2020
$97
2019
$1,104
2018
$267
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$322
Amgen Inc.
$294
E.R. Squibb & Sons, L.L.C.
$263
Alexion Pharmaceuticals, Inc.
$174
Janssen Biotech, Inc.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$108
CSL Behring
$74
TerSera Therapeutics LLC
$54
Incyte Corporation
$53
Exelixis Inc.
$42
Celgene Corporation
$40
Bayer HealthCare Pharmaceuticals Inc.
$36
Gilead Sciences, Inc.
$33
PFIZER INC.
$32
Genentech USA, Inc.
$32
Taiho Oncology, Inc.
$23
AbbVie, Inc.
$23
Hologic Sales and Service, LLC
$22
Pharmacyclics LLC, An AbbVie Company
$21
GENZYME CORPORATION
$20
Astellas Pharma US Inc
$15
Rigel Pharmaceuticals, Inc.
$13
Cardinal Health 414, LLC
$11
Top 3 companies account for 48.1% of total payments
Associated products mentioned in payments ›
APTIMA · Blincyto · CRESEMBA · Cabometyx · DARZALEX · ERLEADA · GAUCHER-DISEASE · IMFINZI · Imbruvica · JAKAFI · Kcentra · Kyprolis · Lonsurf · Lymphoseek · Neulasta · OPDIVO · Revlimid · SOLIRIS · TAGRISSO · Tavalisse · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · Venclexta · Vitrakvi · XGEVA · XTANDI · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
16
Per 100K population
3.9
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mogollon Duffo is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mogollon Duffo experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Mogollon Duffo performed 11,250 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mogollon Duffo receive payments from pharmaceutical companies?
Yes. Dr. Mogollon Duffo received a total of $1,826 from 23 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mogollon Duffo's costs compare to other hematologists in Kissimmee?
Dr. Mogollon Duffo's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mogollon Duffo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Kissimmee
Browse hematologists in Kissimmee ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology